High Blood Pressure
Also known as: Benign essential hypertension, Essential hypertension, HBP, HTN, Hypertension
Methodology & AI Transparency ⓘ
High Blood Pressure Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What is blood pressure? Blood pressure is the force of your blood pushing against the walls of your arteries.
- 2 Real-world patient consensus: Mapped to High Blood Pressure & Vascular Health under ICD-10-CM I10 for High Blood Pressure clinical workups.
- 3 Typical cash cost range: Workup highlights for High Blood Pressure (I10): segmental arterial Doppler in High Blood Pressure (I10: waveforms).
- 4 Top reported side effects / signs: Longitudinal High Blood Pressure monitoring tracks Serum Creatinine & in High Blood Pressure (I10: Potassium) toward K+ 4.0 – 4.8 mEq/L (I10).
Ask our AI Specialists anything about High Blood Pressure
What Is High Blood Pressure?
What is blood pressure? Blood pressure is the force of your blood pushing against the walls of your arteries. Each time your heart beats, it pumps blood into the arteries. Your blood pressure is highest when your heart beats, pumping the blood. This is called systolic pressure. When your heart is at rest, between beats, your blood pressure falls. This is called diastolic pressure. Your blood pressure reading uses these two numbers. Usually the systolic number comes before or above the diastolic number. For example, 120/80 means a systolic of 120 and a diastolic of 80. How is high blood pressure diagnosed? High blood pressure usually has no symptoms.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of High Blood Pressure (I10) center on venous valve incompetence [High Blood Pressure I10]. Cross-referenced with NIH MeSH (Prehypertension, Hypertension), targeted blood pressure interventions aim to normalize Serum Creatinine & in High Blood Pressure (I10: Potassium).
Common Symptoms & Clinical Signs
- • Presentation of High Blood Pressure (I10): persistently elevated home in High Blood Pressure (I10: or clinic blood)
- • Secondary High Blood Pressure clinical sign: morning occipital headache, in High Blood Pressure (I10: pulsatile tinnitus, or)
- • Symptom flares in High Blood Pressure correlating with Serum Creatinine & in High Blood Pressure (I10: Potassium) deviation outside K+ 4.0 – 4.8 mEq/L (I10)
- • Functional blood pressure impact requiring segmental arterial Doppler in High Blood Pressure (I10: waveforms) evaluation (I10)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
High Blood Pressure Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I10 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | High Blood Pressure & Vascular Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Serum Creatinine & in High Blood Pressure (I10: Potassium) | K+ 4.0 – 4.8 mEq/L (I10) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Urine Albumin-to-Creatinine Ratio [High Blood Pressure I10] | < 15 mg/g (I10) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Home Seated Blood in High Blood Pressure (I10: Pressure) | < 120/75 mmHg (I10) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for High Blood Pressure
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Sudafed Sinus 12 Hour Pressure Plus Pain (Naproxen Sodium and Pseudoephedrine Hydrochloride) Sudafed Sinus 12 Hour Pressure Plus Pain • RxCUI 1367426 | Nonsteroidal Anti-inflammatory Drug | 80% | $0.1442 | $ 18.88 /mo |
| Latanoprostene Bunod Vyzulta • RxCUI 1988394 | FDA Prescription Therapeutic Agent | 78% | $99.2842 | $ 185.00 /mo |
| Latanoprost Ophthalmic Solution 0.005% Iyuzeh • RxCUI 314072 | Prostaglandin Analog | 75% | $10.1187 | $ 185.00 /mo |
| Travoprost Travatan Z • RxCUI 284008 | Prostaglandin Analog | 93% | $94.1791 | $ 15.22 /mo |
| Mylanta Gas Minis Assorted Fruit Flavor (Simethicone) Mylanta Gas Minis Assorted Fruit Flavor • RxCUI 314221 | Skin Barrier Activity | 83% | $0.0473 | $ 11.90 /mo |
| Brimonidine Tartrate and Timolol Maleate Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, Brimonidine Tartrate/Timolol Maleate • RxCUI 861635 | alpha-Adrenergic Agonist | 92% | $1.8390 | $ 82.98 /mo |
| Dorzolamide Hydrochloride Timolol Maleate Cosopt • RxCUI 1923432 | Carbonic Anhydrase Inhibitor | 93% | $0.8853 | $ 10.75 /mo |
| Angiotensin Ii Giapreza • RxCUI 1999007 | Vasoconstrictor | 84% | $3.3000 | $ 142.15 /mo |
| Gas Relief Ultra Strength (Simethicone) Gas Relief Ultra Strength • RxCUI 252294 | Skin Barrier Activity | 76% | $0.0473 | $ 11.90 /mo |
| Triderma Pressure Sore Relief (Calendula Officinalis) Triderma Pressure Sore Relief • RxCUI RXN-B10738210 | Over-the-Counter Clinical Monograph | 78% | $2.1600 | $ 164.02 /mo |
| Tafluprost Opthalmic Tafluprost Opthalmic Generic • RxCUI 1244611 | Prostaglandin Analog | 83% | $2.3465 | $ 103.53 /mo |
| Bimatoprost Lumigan, Latisse • RxCUI 308739 | Prostaglandin Analog | 84% | $3.8249 | $ 15.06 /mo |
| Travoprost Ophthalmic Solution Travoprost Ophthalmic Solution Generic • RxCUI RXN-42571130-946 | Prostaglandin Analog | 89% | $7.9822 | $ 185.00 /mo |
| Mannitol Osmitrol • RxCUI 206536 | Osmotic Diuretic | 87% | $2.8600 | $ 124.33 /mo |
| Proparacaine Hydrochloride Alcaine • RxCUI 1191013 | Local Anesthetic | 89% | $1.4173 | $ 35.99 /mo |
| Pressure, Pain and Mucus (Acetaminophen, Guaifenesin, Phenylephrine HCl) Pressure, Pain and Mucus • RxCUI 1243679-B794815072 | Expectorant | 85% | $0.0194 | $ 9.90 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (High Blood Pressure)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Achieved blood pressure and heart and blood vessel outcomes in high-risk: What a 8,407-Participant Study Found Mean achieved SBP less than 120 mm Hg during treatment was associated with increased risk of heart and blood vessel outcomes except for heart attack and stroke. Lancet (London, England) • 2017-06-03 • Meta-Analysis | N = 8,407 | 99/100 | PMID 28390695 ↗ |
| New Insights on Oral semaglutide on heart and blood vessel: What a 13,875-Participant Study Found The meta-analysis revealed that oral semaglutide was cardioprotective in T2DM patients with consistent reductions in heart and blood vessel event risk. International journal of cardiology • 2025-12-01 • Meta-Analysis | N = 13,875 | 99/100 | PMID 40752805 ↗ |
| New Insights on Major outcomes in high-risk hypertensive patients randomized to: What a 9,048-Participant Study Found Thiazide-type diuretics are superior in preventing 1 or more major forms of CVD and are less expensive. JAMA • 2002-12-18 • Randomized Controlled Trial | N = 9,048 | 96/100 | PMID 12479763 ↗ |
| New Insights on Heart and blood vessel outcomes in high-risk hypertensive patients stratified by: What a 8,126-Participant Study Found Older high-risk patients with high blood pressure and reduced GFR are more likely to develop CHD than to develop ESRD. Annals of internal medicine • 2006-02-07 • Randomized Controlled Trial | N = 8,126 | 96/100 | PMID 16461961 ↗ |
| New Insights on Glucose levels predict hospitalization for congestive heart failure in patients: What a 25,620-Participant Study Found Fasting plasma glucose is an independent predictor of hospitalization for CHF in high-risk subjects. Circulation • 2007-03-20 • Randomized Controlled Trial | N = 25,620 | 96/100 | PMID 17339550 ↗ |
High Blood Pressure Patient Community & “People Like Me” Threads
Filter High Blood Pressure community threads and patient logs by age, biological sex, dosage, and treatment duration.